JAKARTA - Co-founder & President Director of Mandaya Hospital Group, Dr. Ben Widaja, MBChB (UK), officially entered the FORTUNE Indonesia 40 Under 40 list of 2026.
This recognition is given to young leaders who have managed to create significant impact in their fields before the age of 40.
The FORTUNE Indonesia 40 Under 40 list highlights inspiring figures from various sectors, from business to government, who are able to translate visions and strategies into real change.
The inclusion of Dr. Ben, who is still 38 years old, in this list reflects the major transformation he has pushed for in the private healthcare system in Indonesia.
Under his leadership, Mandaya Royal Hospital Puri has grown rapidly not only in terms of medical services, but also in terms of governance and financial performance.
Mandaya Royal Hospital Puri managed to break into the top 10 hospitals with the highest revenue in Indonesia within two years of operating.
In addition, Mandaya also recorded positive EBITDA in six months and positive net profit in the first 18 months of operations.
"This recognition is not just about me, but about how Mandaya strives to bring a new standard of health services in Indonesia - combining clinical quality, technology, and patient experience that is truly human-centered," said Dr. Ben Widaja in his statement, Monday, February 16.
Dr. Ben, who studied at the Faculty of Biology, Medicine, and Health, University of Manchester Medical School, England, and earned a Bachelor of Medicine, Bachelor of Surgery (MBChB (UK)), is known as an important figure behind the presence of various cutting-edge medical technologies in Mandaya and Indonesia.
The background of international medical education strengthens his vision in presenting world-class health service standards.
One of his breakthroughs is to introduce the first Zamenix robot arm in Southeast Asia for more precise, low-risk kidney stone actions and to increase the accuracy of procedures for patients.
Mandaya is also the only private hospital in Indonesia that holds two organ transplant licenses at once, namely kidney and liver transplants.
In the field of oncology, Mandaya presents a comprehensive cancer center with Digital PET CT Scan services, Nuclear Medicine, Elekta Versa HD Linac Radiotherapy, Brachytherapy, Immunotherapy, ICG Cancer Surgery, Apheresis for blood cancer, to HIPEC for cases of colon cancer and ovarian cancer that spread to the abdominal cavity.
Various other innovative technologies were also introduced, such as Rezum for benign prostate enlargement, HIFU (High Intensity Focused Ultrasound) for treating uterine fibroids without surgery, Cryotherapy for lung cancer, and PFA (Pulsed Field Ablation) for cardiac ablation.
Under his leadership at Mandaya Hospital Group, dr. Ben built a service approach that started from the view that the patient is a whole individual with needs that go beyond the clinical aspect.
According to him, hospitals are not enough to be a place of treatment, but must be a recovery room that presents a sense of security, comfort, and appreciation.
This principle is realized through the implementation of the concept of patient-centered care in a comprehensive manner.
Its services are designed not only to focus on diagnosis and medical actions, but also to pay attention to the emotional, psychological, social, and spiritual conditions of patients and their families.
To implement this vision, Dr. Ben integrates three main foundations, namely close collaboration between experienced specialists, the use of cutting-edge medical technology with global standards, and the presence of a patient experience team that ensures that the non-medical needs of patients are met comprehensively.
For him, a superior hospital is an institution that is able to maintain patient dignity, present empathy in every treatment process, and ensure a humane experience at every stage of the health journey.
Thanks to his innovative leadership, Dr. Ben also gained global recognition through various awards, including CEO of the Year 2023 (Healthcare Asia Awards), CEO of the Year 2024 (Healthcare Management Excellence Awards), and Entrepreneurial Spirit Award 2025 (EY Consulting).
With a strong vision, measurable strategies, and the courage to innovate, Dr. Ben is considered worthy of being one of the most influential health figures in Indonesia today.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
